Novel 4-Aminoquinoline Analogs Targeting the HIF-1α Signaling Pathway

References

• Chung PY , BianZX , PunHYet al. Recent advances in research of natural and synthetic bioactive quinolines. Future Med. Chem.7(7), 947–967 (2015).
   PubMed Web of Science ®Google Scholar
• Marella A , TanwarOP , SahaRet al. Quinoline: a versatile heterocyclic. Saudi Pharm. J.21(1), 1–12 (2013).
   PubMed Web of Science ®Google Scholar
• Murugan K , PanneerselvamC , SubramaniamJet al. Synthesis of new series of quinoline derivatives with insecticidal effects on larval vectors of malaria and dengue diseases. Sci. Rep.12(1), 4765 (2022).
   PubMed Web of Science ®Google Scholar
• Swain SS , PatiS , HussainT. Quinoline heterocyclic containing plant and marine candidates against drug-resistant Mycobacterium tuberculosis: a systematic drug-ability investigation. Eur. J. Med. Chem.232, doi: 10.1016/j.ejmech.2022.114173 (2022).
   PubMed Web of Science ®Google Scholar
• Patel KB , KumariP. A review: structure-activity relationship and antibacterial activities of quinoline based hybrids. J. Mol. Struct.1268, doi: 10.1016/j.molstruc.2022.133634 (2022).
   Web of Science ®Google Scholar
• Musharrafieh R , ZhangJ , TuohyPet al. Discovery of quinoline analogues as potent antivirals against enterovirus D68 (EV-D68). J. Med. Chem.62(8), 4074–4090 (2019).
   PubMed Web of Science ®Google Scholar
• Noori M , DavoodiA , IrajiAet al. Design, synthesis, and in silico studies of quinoline-based-benzo[d]imidazole bearing different acetamide derivatives as potent α-glucosidase inhibitors. Sci. Rep.12, 14019 (2022).
   PubMed Web of Science ®Google Scholar
• Kaschula CH , EganTJ , HunterRet al. Structure-activity relationships in 4-aminoquinoline antiplasmodials. The role of the group at the 7-position. J. Med. Chem.45(16), 3531–3539 (2002).
   PubMed Web of Science ®Google Scholar
• Zhang H , SolomonVR , HuC , UlibarriG , LeeH. Synthesis and in vitro cytotoxicity evaluation of 4-aminoquinoline derivatives. Biomed. Pharmacother.62(2), 65–69 (2008).
   PubMed Web of Science ®Google Scholar
• Ray S , MadridPB , CatzPet al. Development of a new generation of 4-aminoquinoline antimalarial compounds using predictive pharmacokinetic and toxicology models. J. Med. Chem.53(9), 3685–3695 (2010).
   PubMed Web of Science ®Google Scholar
• Rajapakse CSK , LisaiM , DeregnaucourtCet al. Synthesis of new 4-aminoquinolines and evaluation of their in vitro activity against chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum. PLOS ONE10(10), e0140878 (2015).
   PubMed Web of Science ®Google Scholar
• Lawrenson AS , CooperDL , O'NeillPM , BerryNG. Study of the antimalarial activity of 4-aminoquinoline compounds against chloroquine-sensitive and chloroquine-resistant parasite strains. J. Mol. Model.24(9), 237 (2018).
   PubMed Web of Science ®Google Scholar
• Paz JD , Denisede Moura Sperotto N , RamosASet al. Novel 4-aminoquinolines: synthesis, inhibition of the Mycobacterium tuberculosis enoyl-acyl carrier protein reductase, antitubercular activity, SAR, and preclinical evaluation. Eur. J. Med. Chem.245, doi: 10.1016/j.ejmech.2022.114908 (2023).
   PubMed Web of Science ®Google Scholar
• Basilico N , ParapiniS , SparatoreAet al. In vivo and in vitro activities and ADME-tox profile of a quinolizidine-modified 4-aminoquinoline: a potent anti-P. falciparum and anti-P. vivax blood-stage antimalarial. Molecules22(12), 2102 (2017).
   PubMed Web of Science ®Google Scholar
• Nandi S , ChauhanB , TarannumH , KhedeMK. Multi-target polypharmacology of 4-aminoquinoline compounds against malaria, tuberculosis and cancer. Curr. Top. Med. Chem.23(5), 403–414 (2023).
   PubMed Web of Science ®Google Scholar
• Parhizgar AR , TahghighiA. Introducing new antimalarial analogues of chloroquine and amodiaquine: a narrative review. Iran. J. Med. Sci.42(2), 115–128 (2017).
   PubMed Web of Science ®Google Scholar
• Eric Scholar . Amodiaquine. In: xPharm: The Comprehensive Pharmacology Reference.EnnaSJ, BylundDB ( Eds). Elsevier, Amsterdam, The Netherlands, 1–4 (2007).
   Google Scholar
• Oh S , ShinJH , JangEJet al. Anti-inflammatory activity of chloroquine and amodiaquine through p21-mediated suppression of T cell proliferation and Th1 cell differentiation. Biochem. Biophys. Res. Commun.474(2), 345–350 (2016).
   PubMed Web of Science ®Google Scholar
• Ng W , LobachAR , ZhuXet al. Animal models of idiosyncratic drug reactions. Adv. Pharmacol.63, 81–135 (2012).
   PubMedGoogle Scholar
• Romero AH , AcostaME , GamboaN , CharrisJE , SalazarJ , LópezSE. Synthesis, β-hematin inhibition studies and antimalarial evaluation of dehydroxy isotebuquine derivatives against Plasmodium berghei. Bioorg. Med. Chem.23(15), 4755–4762 (2015).
   PubMed Web of Science ®Google Scholar
• Singh S , AgarwalD , SharmaKet al. 4-Aminoquinoline derivatives: synthesis, in vitro and in vivo antiplasmodial activity against chloroquine-resistant parasites. Eur. J. Med. Chem.122, 394–407 (2016).
   PubMed Web of Science ®Google Scholar
• Miroshnikova OV , HudsonTH , GerenaL , KyleDE , LinAJ. Synthesis and antimalarial activity of new isotebuquine analogues. J. Med. Chem.50(4), 889–896 (2007).
   PubMed Web of Science ®Google Scholar
• Sharma P , ChhabraS , RaiN , GhoshalN. Exploration of rate-limiting conformational state for 5-[(7-chloro-4-quinolinyl)amino]-3-[(alkylamino)methyl][1,1′-biphenyl]-2-ols and nω-oxides (tebuquine analogues) for antimalarial activity using molecular shape analysis and molecular field analysis studies. J. Chem. Inf. Model.47, 1087–1096 (2007).
   PubMed Web of Science ®Google Scholar
• Romero AH , LópezSE , ArveloF , SojoF , CalderonC , MoralesA. Identification of dehydroxy isoquine and isotebuquine as promising anticancer agents targeting K+ channel. Chem. Biol. Drug Des.93(4), 638–646 (2019).
   PubMed Web of Science ®Google Scholar
• Solomon VR , PundirS , LeeH. Examination of novel 4-aminoquinoline derivatives designed and synthesized by a hybrid pharmacophore approach to enhance their anticancer activities. Sci. Rep.9, 6315 (2019).
   PubMed Web of Science ®Google Scholar
• Pundir S , VuHY , SolomonVR , McClureR , LeeH. VR23: a quinoline-sulfonyl hybrid proteasome inhibitor that selectively kills cancer via cyclin E-mediated centrosome amplification. Cancer Res.75(19), 4164–4175 (2015).
   PubMed Web of Science ®Google Scholar
• Solomon VR , PundirS , LeeH. Design and synthesis of 4-piperazinyl quinoline derived urea/thioureas for anti-breast cancer activity by a hybrid pharmacophore approach. J. Enzyme Inhib. Med. Chem.34(1), 620–630 (2019).
   PubMed Web of Science ®Google Scholar
• Bhat HR , MasihA , ShakyaA , GhoshSK , SinghUP. Design, synthesis, anticancer, antibacterial, and antifungal evaluation of 4-aminoquinoline-1,3,5-triazine derivatives. J. Heterocyclic Chem.57, 390–399 (2020).
   Web of Science ®Google Scholar
• Krstulović L , LeventićM , RastijaV. Novel 7-chloro-4-aminoquinoline-benzimidazole hybrids as inhibitors of cancer cells growth: synthesis, antiproliferative activity, in silico ADME predictions, and docking. Molecules28(2), 540 (2023).
   PubMed Web of Science ®Google Scholar
• Tam SY , WuVWC , LawHKW. Hypoxia-induced epithelial-mesenchymal transition in cancers: HIF-1α and beyond. Front. Oncol.10, 486 (2020).
   PubMed Web of Science ®Google Scholar
• Rehman Z , JabeenI , FahimA , BhattiA , JohnP. Molecular docking and pharmacophore models to probe binding hypothesis of inhibitors of hypoxia inducible factor-1. J. Biomol. Struct. Dyn.40(17), 7714–7725 (2022).
   PubMed Web of Science ®Google Scholar
• Ma S , WangF , DongJet al. Inhibition of hypoxia-inducible factor 1 by acriflavine renders glioblastoma sensitive for photodynamic therapy. J. Photochem. Photobiol. B234, doi: 10.1016/j.jphotobiol.2022.112537 (2022).
   Web of Science ®Google Scholar
• Manuelli V , PecorariC , FilomeniG , ZitoE. Regulation of redox signaling in HIF-1-dependent tumor angiogenesis. FEBS J.289(18), 5413–5425 (2022).
   PubMed Web of Science ®Google Scholar
• Zheng Z , XuT , LiuZet al. Cryptolepine suppresses breast adenocarcinoma via inhibition of HIF-1 mediated glycolysis. Biomed. Pharmacother.153, doi: 10.1016/j.biopha.2022.113319 (2022).
   Web of Science ®Google Scholar
• Yeo EJ , ChoYS , KimMS , ParkJW. Contribution of HIF-1α or HIF-2α to erythropoietin expression: in vivo evidence based on chromatin immunoprecipitation. Ann. Hematol.87(1), 11–17 (2008).
   PubMed Web of Science ®Google Scholar
• Shang FF , WangJY , XuQet al. Design, synthesis of novel celastrol derivatives and study on their antitumor growth through HIF-1a pathway. Eur. J. Med. Chem.220, doi: 10.1016/j.ejmech.2021.113474 (2021).
   PubMed Web of Science ®Google Scholar
• Ma Z , XiangX , LiSet al. Targeting hypoxia-inducible factor-1, for cancer treatment: recent advances in developing small-molecule inhibitors from natural compounds. Semin. Cancer Biol.80, 379–390 (2022).
   PubMed Web of Science ®Google Scholar
• Nagle DG , ZhouYD. Natural product-based inhibitors of hypoxia-inducible factor-1 (HIF-1). Curr. Drug Targets7(3), 355–569 (2006).
   PubMed Web of Science ®Google Scholar
• Wu YC , LuMT , LinTH , ChuPC , ChangCS. Synthesis and evaluation of biarylquinoline derivatives as novel HIF-1α inhibitors. Bioorg. Chem.121, doi: 10.1016/j.bioorg.2022.105681 (2022).
   Web of Science ®Google Scholar
• Shu B , ZengP , KangSet al. Syntheses and evaluation of new quinoline derivatives for inhibition of hnRNP K in regulating oncogene C-myc transcription. Bioorg. Chem.85, 1–17 (2019).
   PubMed Web of Science ®Google Scholar
• Yao C , WangF. Inhibition of hypoxia-induced HIF-1α-mediated autophagy enhances the in vitro antitumor activity of rhein in pancreatic cancer cells. J. Appl. Toxicol.42(12), 1937–1947 (2022).
   PubMed Web of Science ®Google Scholar
• Liu L , LiuW , WangL , ZhuT , ZhongJ , XieN. Hypoxia-inducible factor 1 mediates intermittent hypoxia-induced migration of human breast cancer MDA-MB-231 cells. Oncol. Lett.14(6), 7715–7722 (2017).
   PubMed Web of Science ®Google Scholar
• Tošić I , FrankDA. STAT3 as a mediator of oncogenic cellular metabolism: pathogenic and therapeutic implications. Neoplasia23(12), 1167–1178 (2021).
   PubMed Web of Science ®Google Scholar
• Niu G , BriggsJ , DengJet al. Signal transducer and activator of transcription 3 is required for hypoxia-inducible factor-1α RNA expression in both tumor cells and tumor-associated myeloid cells. Mol. Cancer Res.6(7), 1099–1105 (2008).
   PubMed Web of Science ®Google Scholar